Compound ID | 1050
Class: Beta-lactam (penicillin)
Spectrum of activity: | Gram-negative |
Propensity to select resistant mutants: | Yes |
Description: | Beta lactam, highly active against Pseudomonas. Dropped because of toxicity problems. |
Institute where first reported: | Sumito Chemical |
Year first mentioned: | 1975 |
Highest developmental phase: | Preclinical |
Chemical structure(s): | |
Canonical SMILES: | CC1(C)[C@H](C(=O)O)N2C(=O)[C@H]([C@H]2S1)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)C4=CNC5=CC=CN=C5C4=O |
Isomeric SMILES: | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)C4=CNC5=C(C4=O)N=CC=C5)C(=O)O)C |
InChI: | InChI=1S/C25H23N5O6S/c1-25(2)19(24(35)36)30-22(34)17(23(30)37-25)29-21(33)15(12-7-4-3-5-8-12)28-20(32)13-11-27-14-9-6-10-26-16(14)18(13)31/h3-11,15,17,19,23H,1-2H3,(H,27,31)(H,28,32)(H,29,33)(H,35,36)/t15-,17-,19+,23-/m1/s1 |
InChI Key: | XMQVYNAURODYCQ-SLFBBCNNSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/6602341 |
External links: | |
Guide to Pharmacology: | apalcillin |
Citation: | https://www.ncbi.nlm.nih.gov/pubmed/1046355 |